相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gene Polymorphisms of the Renin-Angiotensin System and Bleeding Complications of Warfarin: Genetic-Based Machine Learning Models
Joo-Hee Kim et al.
PHARMACEUTICALS (2021)
An Angiotensinogen Gene Polymorphism (rs5050) Is Associated with the Risk of Coronary Artery Aneurysm in Southern Chinese Children with Kawasaki Disease
Yunfeng Liu et al.
DISEASE MARKERS (2019)
Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic Variants
Sri H. Kanuri et al.
JOURNAL OF PERSONALIZED MEDICINE (2019)
Is there a role for pharmacokinetic/pharmacodynamic-guided dosing for novel oral anticoagulants?
Noel Chan et al.
AMERICAN HEART JOURNAL (2018)
Clinical Review of the Pharmacogenomics of Direct Oral Anticoagulants
Andrew S. Tseng et al.
CARDIOVASCULAR DRUGS AND THERAPY (2018)
Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs)
Paolo Gelosa et al.
PHARMACOLOGICAL RESEARCH (2018)
Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma
Alexander Perdomo-Pantoja et al.
PLOS ONE (2018)
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study
Gregory Y. H. Lip et al.
STROKE (2018)
Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis
S. Deitelzweig et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
Genetic effects on gene expression across human tissues
Francois Aguet et al.
NATURE (2017)
Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation A Systematic Review and Meta-Analysis
George Ntaios et al.
STROKE (2017)
Comparison of the CHA2DS2-VASc, CHADS2, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation
Xiaoxi Yao et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease
Lucas D. Ward et al.
NUCLEIC ACIDS RESEARCH (2016)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2016)
Gene polymorphisms and the risk of warfarin-induced bleeding complications at therapeutic international normalized ratio (INR)
Leyla Pourgholi et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)
Sebastian Werth et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2015)
New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events
Agon Mekaj et al.
Therapeutics and Clinical Risk Management (2015)
AGT A-20C (rs5050) gene polymorphism and ulcer occurrence in patients treated with low-dose aspirin: a case-control study
Anca Negovan et al.
REVISTA ROMANA DE MEDICINA DE LABORATOR (2015)
Haemostasis in chronic kidney disease
Jens Lutz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Importance of Pharmacokinetic Profile and Variability as Determinants of Dose and Response to Dabigatran, Rivaroxaban, and Apixaban
Inna Y. Gong et al.
CANADIAN JOURNAL OF CARDIOLOGY (2013)
Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial
Stavros Apostolakis et al.
EUROPEAN HEART JOURNAL (2013)
Assessing bleeding risk in patients taking anticoagulants
Marwa Shoeb et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Single Nucleotide Polymorphisms of the Angiotensin-Converting Enzyme (ACE) Gene Are Associated with Essential Hypertension and Increased ACE Enzyme Levels in Mexican Individuals
Nancy Martinez-Rodriguez et al.
PLOS ONE (2013)
Epistatic effects of ACE I/D and AGT gene variants on left ventricular mass in hypertensive patients: the HyperGEN study
A. I. Lynch et al.
JOURNAL OF HUMAN HYPERTENSION (2012)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey
Ron Pisters et al.
CHEST (2010)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The renin-angiotensin aldosterone system: Pathophysiological role and pharmacologic inhibition
Steven A. Atlas
JOURNAL OF MANAGED CARE PHARMACY (2007)
Renin-angiotensin system and cardiovascular risk
Roland E. Schmieder et al.
LANCET (2007)
Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)
BF Gage et al.
AMERICAN HEART JOURNAL (2006)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Haploview: analysis and visualization of LD and haplotype maps
JC Barrett et al.
BIOINFORMATICS (2005)
Genomic variants in exons and introns: identifying the splicing spoilers
F Pagani et al.
NATURE REVIEWS GENETICS (2004)
High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity
F Soubrier et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2002)
Aspects of gene polymorphisms in cardiovascular disease: the renin-angiotensin system
M Carluccio et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2001)
Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease
JG Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
分享论文
